Blar i NTNU Open på forfatter "Heck, Siri Lagethon"

Viser treff 1-3 av 3

    • Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity 

      Myhre, Peder Langeland; Heck, Siri Lagethon; Skranes, Julia Brox; Prebensen, Christian Haugland; Jonassen, Christine M; Berge, Trygve; Mecinaj, Albulena; Einvik, Gunnar; Melles, Woldegabriel A; Ingul, Charlotte Bjørk; Tveit, Arnljot; Berdal, Jan-Erik; Røsjø, Helge Rørvik; Lyngbakken, Magnus Nakrem; Omland, Torbjørn (Peer reviewed; Journal article, 2021)
      Background Coronavirus disease 2019 (COVID-19) may cause myocardial injury and myocarditis, and reports of persistent cardiac pathology after COVID-19 have raised concerns of long-term cardiac consequences. We aimed to ...

    • Minor Myocardial Scars in Association with Cardiopulmonary Function after COVID-19 

      Øvrebotten, Tarjei; Heck, Siri Lagethon; Skjørten, Ingunn; Einvik, Gunnar; Stavem, Knut; Ingul, Charlotte Ingeborg Björk; Omland, Torbjørn; Myhre, Peder Langeland (Peer reviewed; Journal article, 2023)
      Background: Myocardial scars detected by cardiovascular magnetic resonance (CMR) imaging after COVID-19 have caused concerns regarding potential long-term cardiovascular consequences. Objective: The objective of this study ...

    • Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial 

      Mecinaj, Albulena; Gulati, Geeta; Heck, Siri Lagethon; Holte, Espen; Fagerland, Morten Wang; Larsen, Alf Inge; Blix, Egil Støre; Geisler, Jürgen; Wethal, Torgeir; Omland, Torbjørn (Journal article, 2021)
      Background Recent advances in the treatment algorithms of early breast cancer have markedly improved overall survival. However, anthracycline- and trastuzumab-associated cardiotoxicity may lead to dose-reduction or halt ...